Mupirocin
Bactroban and Bactroban 2% are different trade names for the same medicine.
Bactroban nasal ointment (referred to as Bactroban in this leaflet) contains the antibiotic
called mupirocin in the form of calcium mupirocin.
It is used:
This ointment is intended for use in the nose only.
If the patient is allergic to mupirocin or any of the other ingredients of Bactroban
(listed in section 6).
In case of doubts related to the use of the medicine, the doctor or pharmacist should be consulted.
The doctor or pharmacist should be informed about all medicines currently being taken or
recently taken, including those that are available without a prescription and herbal medicines, as well as medicines that the patient plans to take.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
This medicine should always be used as directed by the doctor or pharmacist. In case of doubts,
the doctor or pharmacist should be consulted.
Bactroban should be introduced into the nose 2 times a day.
Instead of a small finger to introduce the medicine into the nose, cosmetic sticks can be used.
Special precautions should be taken in these patients. Bactroban should not be used in newborns and infants.
Bactroban should be used for as long as the doctor recommends. In case of doubts,
the doctor or pharmacist should be consulted. Usually, the bacteria in the nose die
after 3-5 days of treatment.
Bactroban should not be used for more than 10 days.
In case of using more than the recommended dose of Bactroban, the doctor or pharmacist should be consulted. Excess ointment should be carefully removed.
If Bactroban is swallowed, the doctor should be consulted immediately, informing them of what and how much was swallowed.
If the patient forgets to use the medicine, they should use it as soon as they remember. If the time for the next dose is within an hour, the missed dose should be skipped.
A double dose should not be used to make up for a missed dose.
If the patient stops using Bactroban too early, not all bacteria may be killed
or may continue to multiply. The doctor or pharmacist should be asked when to stop using the ointment.
In case of doubts related to the use of the medicine, the doctor or pharmacist should be consulted.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects may occur:
Uncommon(may affect up to 1 in 100 people):
In rare cases, medicines like Bactroban nasal ointment may cause colitis (inflammation of the colon) - characterized by the appearance of diarrhea, usually bloody and containing mucus, abdominal pain, fever ( pseudomembranous colitis).
If such symptoms occur, the doctor should be consulted as soon as possible.
If any side effects occur, including any side effects not listed in the leaflet, the doctor, pharmacist, or nurse should be informed. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: + 48 22 49 21 301
fax: + 48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
By reporting side effects, more information can be gathered on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not store above 25°C.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Do not use Bactroban if it looks different from normal (see description in point 6).
Medicines should not be disposed of via wastewater or household waste. The pharmacist should be asked how to dispose of medicines that are no longer needed. This will help protect the environment.
Bactroban is a white ointment with a uniform consistency. The medicine is available in aluminum tubes containing 3g of ointment, in a cardboard box.
For more detailed information, the marketing authorization holder or parallel importer should be consulted.
Laboratoire GlaxoSmithKline, 23, rue François Jacob, 92500 Rueil-Malmaison, France
GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24,
Ireland
Delpharm Poznań Spółka Akcyjna, ul. Grunwaldzka 189, 60-322 Poznań, Poland
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
French marketing authorization number, country of export: 34009 363 416 5 4
34009 363 417 1 5
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.